Kabbinavar, Fairooz
Mayo Clinic
From Vanderbilt University Medical Center (L. Horn) and Sarah Cannon Research Institute-Tennessee Oncology (M.L.J.), Nashville; Mayo Clinic, Rochester, MN (A.S.M.); Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy, Otwock (A. Szczęsna), and Centrum Onko
Citations 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Horn, Leora , Mansfield, Aaron S. , Szczęsna, Aleksandra, Havel, Libor , Krzakowski, Maciej , Losonczy, György , Nishio, Makoto , Reck, Martin , Mok, Tony , Lam, Sivuonthanh, Shames, David S. , Liu, Juan , Ding, Beiying, López-Chávez, Ariel, Kabbinavar, Fairooz F. , Sandler, Alan , Liu, Stephen V. , Melichar, Bohuslav , Garassino, Marina Chiara , Buti, Sebastiano , Kowalski, Dariusz M. , Tomasini, Pascale , Cortot, Alexis B. , Hochmair, Maximilian J, Huemer, Florian, Johnson, Melissa L. , Kabbinavar, Fairooz, Karapanagiotou, Eleni , Mansfield, Aaron S , Hochmair, Maximilian Johannes , Huemer, Florian , Lin, Wei Y. , Cortot, Alexis B , Tomasini, Pascale , Kowalski, Dariusz , Liu, Stephen V
New England Journal of Medicine | September 25, 2018 | Volume: 379 | Issue: 23 | Pages: 2220-2229
